Summary of Study ST002420

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001558. The data can be accessed directly via it's Project DOI: 10.21228/M89M65 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002420
Study TitleColorectal cancer isobaric labeling for metabolite quantification
Study SummaryA major challenge in reducing the death rate of colorectal cancer is to screen patients using low-invasive testing. Blood test shows a high compliance rate with reduced invasiveness. In this work, a multiplex isobaric tag labeling strategy coupled with mass spectrometry is adopted to relatively quantify primary and secondary amine-containing metabolites in serum for the discovery of metabolite biomarkers of colorectal cancer. Serum samples from patients at different risk statuses and colorectal cancer growth statuses are studied. Metabolite identification is based on accurate mass matching and/or retention time of labeled metabolite standards. We quantify 40 metabolites across all the serum samples, including 18 metabolites validated with standards. We find significantly decreased levels of threonine and asparagine in the patients with growing adenomas or high-risk adenomas (p < 0.05). Glutamine levels decrease in patients with adenomas of unknown growth status or high-risk adenomas. In contrast, arginine levels are elevated in patients with low-risk adenoma. Receiver operating characteristic analysis shows high sensitivity and specificity of these metabolites for detecting growing adenomas. Based on these results, we conclude that potential metabolite biomarkers identified here contribute to distinguishing colorectal patients with growing adenomas from normal individuals and patients with unknown growth status of adenomas.
Institute
University of Wisconsin - Madison
Last NameLiu
First NameYuan
Address777 Highland ave, Madison, Wisconsin, 53705, USA
Emailliu788@wisc.edu
Phone6089606939
Submit Date2022-12-28
Raw Data AvailableYes
Raw Data File Type(s)mzML
Analysis Type DetailLC-MS
Release Date2023-03-31
Release Version1
Yuan Liu Yuan Liu
https://dx.doi.org/10.21228/M89M65
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Factors:

Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id classification_based on growth rate classification_based on risks
SA242323N14control control
SA242324N13control control
SA242325N11control control
SA242326N15control control
SA242327N12control control
SA242328N17control control
SA242329N10control control
SA242330N19control control
SA242331N18control control
SA242332N20control control
SA242333N16control control
SA242334N5control control
SA242335N9control control
SA242336N2control control
SA242337N1control control
SA242338N4control control
SA242339N3control control
SA242340N6control control
SA242341N8control control
SA242342N7control control
SA24228123_preGrowing High‐risk
SA24228223_postGrowing High‐risk
SA24228319_postGrowing High‐risk
SA24228419_preGrowing High‐risk
SA24228515_postGrowing High‐risk
SA24228624_preGrowing High‐risk
SA24228725_postGrowing High‐risk
SA24228833_preGrowing High‐risk
SA24228933_postGrowing High‐risk
SA24229028_postGrowing High‐risk
SA24229128_preGrowing High‐risk
SA24229215_preGrowing High‐risk
SA24229325_preGrowing High‐risk
SA24229424_postGrowing High‐risk
SA2422955_preGrowing High‐risk
SA2422968_postGrowing High‐risk
SA2422975_postGrowing High‐risk
SA2422988_preGrowing High‐risk
SA2422997_postGrowing High‐risk
SA2423007_preGrowing High‐risk
SA2423432_postgrowing Low‐Risk
SA2423442_pregrowing Low‐Risk
SA2423019_preGrowing Low‐Risk
SA24230218_postGrowing Low‐Risk
SA24230332_postGrowing Low‐Risk
SA24230432_preGrowing Low‐Risk
SA2423059_postGrowing Low‐Risk
SA24230618_preGrowing Low‐Risk
SA24234520_poststatic High‐risk
SA24234620_prestatic High‐risk
SA2423071_postStatic Low‐Risk
SA2423083_postStatic Low‐Risk
SA2423093_preStatic Low‐Risk
SA2423101_preStatic Low‐Risk
SA24231110_postUnknown High‐risk
SA24231229_postUnknown High‐risk
SA24231329_preUnknown High‐risk
SA24231412_postUnknown High‐risk
SA24231512_preUnknown High‐risk
SA24231621_postUnknown High‐risk
SA24231721_preUnknown High‐risk
SA24231810_preUnknown High‐risk
SA24231911_postUnknown Low‐Risk
SA24232026_preUnknown Low‐Risk
SA24232126_postUnknown Low‐Risk
SA24232211_preUnknown Low‐Risk
Showing results 1 to 66 of 66
  logo